PATENT CLAIM ANALYSIS

Application Number: 15920244
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "130100"]

Abstract:
Disclosed herein are antibodies specific for erythroferrone and assays comprising the antibodies. Also disclosed are methods for using the assays for the diagnosis or monitoring of disease.

Claim (Index 5):
The assay of  claim 1 , wherein the first antibody is 4C1 and the second antibody is 2D2.

Metadata:
- Claim Count in Document: 46.0
- Percentile: 90.0
- Lexical Diversity: 1.38095
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15361936', '14839911', '15141463', '15165150', '13981852']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7928147475883945
- 35 USC 102 Novelty (BERT): 0.538328345815695
- Combined Prediction Score: 0.7673661074111247
- Mean Citation Score: 379.003276
- Max Citation Score: 387.25836
- Similarity Product: 253.5385257467652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test